Aurora Cannabis Strikes Supply Deal with SNDL

Ticker: ACB · Form: 6-K · Filed: 2025-02-07T00:00:00.000Z

Sentiment: neutral

Topics: supply-agreement, cannabis, partnership

Related Tickers: ACB, SNDL

TL;DR

ACB inks supply deal with SNDL for dried flower. Big move for Canadian cannabis.

AI Summary

Aurora Cannabis Inc. announced a supply agreement with SNDL Inc. on February 6, 2025. This agreement allows Aurora to supply dried cannabis flower to SNDL. Miguel Martin, CEO of Aurora Cannabis, signed the report.

Why It Matters

This agreement expands Aurora's market reach by supplying dried cannabis flower to SNDL, potentially increasing revenue and market share in the cannabis industry.

Risk Assessment

Risk Level: medium — The cannabis industry is subject to regulatory changes and market volatility, which can impact Aurora's performance.

Key Players & Entities

FAQ

What is the nature of the agreement between Aurora Cannabis and SNDL?

Aurora Cannabis announced a supply agreement with SNDL Inc. on February 6, 2025, under which Aurora will supply dried cannabis flower to SNDL.

Who signed the report on behalf of Aurora Cannabis?

Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc., signed the report.

What is the filing date of this 6-K report?

The filing date of this 6-K report is February 7, 2025.

Which stock exchanges is Aurora Cannabis listed on?

Aurora Cannabis is listed on NASDAQ and TSX, with the ticker symbol ACB.

What type of report is this filing?

This filing is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

From the Filing

0001279569-25-000110.txt : 20250207 0001279569-25-000110.hdr.sgml : 20250207 20250206213240 ACCESSION NUMBER: 0001279569-25-000110 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20250206 FILED AS OF DATE: 20250207 DATE AS OF CHANGE: 20250206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 25599025 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated February 6, 2025 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: February 6, 2025 EX-99.1 2 ex991.htm NEWS RELEASE DATED FEBRUARY 6, 2025 Exhibit 99.1 Aurora Cannabis Announces Supply Agreement with SNDL NASDAQ | TSX: ACB Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis EDMONTON, AB, February 6, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to announce a strategic supply agreement (the "Agreement") with SNDL Inc. ("SNDL") , a Canadian licensed producer and vertically integrated cannabis enterprise. Under this Agreement, SNDL is expected to supply Aurora with premium cannabis flower product grown at SNDL's indoor facility in Atholville, New Brunswick. The term of the agreement is for three years with an option to extend and an estimated value of $27 million. Aurora and SNDL have an existing and successful supply relationship for the manufacturing of various cannabis products and input material. "Following our strong, third quarter performance driven by record setting growth in our international medical cannabis segment, Aurora remains focused on a balanced approach to operating a hybrid manufacturing network of in-house and third-party cultivation. We value our relationship with SNDL and their shared commitment to cultivation excellence," said Miguel Martin, Executive Chairman and Chief Executive Officer of Aurora Cannabis. "As Canada's leading integrated cannabis company, SNDL is well positioned as a supplier of quality cannabis products to commercial partners like Aurora. We have a shared approach to quality and cultivation excellence and look forward to expanding this relationship further," said Zach George, Chief Executive Officer of SNDL. About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe and Australia. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Aurora Drift, San Rafael

View on Read The Filing